Zobrazeno 1 - 10
of 62
pro vyhledávání: '"LA Albacker"'
Autor:
JS Ross, J Chung, JE Elvin, J-A Vergilio, S Ramkissoon, J Suh, E Severson, S Daniel, GM Frampton, D Fabrizio, RJ Hartmaier, LA Albacker, SM Ali, AB Schrock, VA Miller, PJ Stephens, LM Gay
Publikováno v:
Cancer Research. 78:P2-09
Background: The tropomysin receptor kinase A family includes the 3 NTRK1, NTRK2 and NTRK3 genes and plays major roles in neuronal development. The recent evidence of remarkable efficacy for kinase inhibitors (TKI) targeting NTRK across a wide variety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4b8073a0a60f01beaf32cf13a2c573e
https://doi.org/10.1158/1538-7445.sabcs17-p2-09-15
https://doi.org/10.1158/1538-7445.sabcs17-p2-09-15
Autor:
JS Ross, J Chung, JE Elvin, J-A Vergilio, S Ramkissoon, J Suh, E Severson, S Daniel, GM Frampton, D Fabrizio, RJ Hartmaier, LA Albacker, SM Ali, AB Schrock, VA Miller, PJ Stephens, LM Gay
Publikováno v:
Cancer Research. 78:PD8-01
Background: Typically defined by negative IHC staining for E-cadherin, classic (CILC) and pleomorphic (PILC) are often combined as a single breast cancer subtype. We queried whether patients with relapsed metastatic disease, mCILC and mPILC, would ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02b3a044b20641eb707ff270a21ebb7f
https://doi.org/10.1158/1538-7445.sabcs17-pd8-01
https://doi.org/10.1158/1538-7445.sabcs17-pd8-01
Autor:
Risch Z; The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology/Medical Oncology., Kaffenberger BH; The Ohio State University Wexner Medical Center, Department of Dermatology., Chung CG; The Ohio State University Wexner Medical Center, Department of Pathology., Samorodnitsky E; The Ohio State University James Comprehensive Cancer Center., Hoskins EL; The Ohio State University James Comprehensive Cancer Center; The Ohio State University Biomedical Sciences Graduate Program., Dao T; The Ohio State University James Comprehensive Cancer Center., Smith A; The Ohio State University James Comprehensive Cancer Center., Wall SA; The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology/Medical Oncology., Brammer J; The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology/Medical Oncology., Reeser JW; The Ohio State University James Comprehensive Cancer Center., Wing MR; The Ohio State University James Comprehensive Cancer Center., Hopkins JF; Foundation Medicine Inc.., Albacker LA; Foundation Medicine Inc.., Abruzzo LV; The Ohio State University Wexner Medical Center, Department of Pathology., Eisele CD; The Ohio State University Wexner Medical Center, Department of Pathology; The Ohio State University James Comprehensive Cancer Center; The Ohio State University Biomedical Sciences Graduate Program., Freud AG; The Ohio State University Wexner Medical Center, Department of Pathology., Roychowdhury S; The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Medical Oncology. sameek.roychowdhury@osumc.edu., Walsh KE; Vanderbilt University Medical Center, Department of Internal Medicine, Division of Hematology/Oncology.
Publikováno v:
Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3816-3820. Date of Electronic Publication: 2024 Nov 01.
Autor:
Lin DI; Foundation Medicine, Inc., Boston, MA, USA. dlin@foundationmedicine.com., Quintanilha JCF; Foundation Medicine, Inc., Boston, MA, USA., Danziger N; Foundation Medicine, Inc., Boston, MA, USA., Lang L; Merck & Co., Inc., Rahway, NJ, USA., Levitan D; Merck & Co., Inc., Rahway, NJ, USA., Hayne C; Beth Israel Deaconess Medical Center, Boston, MA, USA., Hiemenz MC; Foundation Medicine, Inc., Boston, MA, USA., Smith DL; Foundation Medicine, Inc., Boston, MA, USA., Albacker LA; Foundation Medicine, Inc., Boston, MA, USA., Leibowitz J; Foundation Medicine, Inc., Boston, MA, USA., Mata DA; Foundation Medicine, Inc., Boston, MA, USA., Decker B; Foundation Medicine, Inc., Boston, MA, USA., Lakis S; Foundation Medicine GmbH, Penzberg, Germany., Patel NR; Foundation Medicine, Inc., Boston, MA, USA., Graf RP; Foundation Medicine, Inc., Boston, MA, USA., Elvin JA; Foundation Medicine, Inc., Boston, MA, USA., Ross JS; Foundation Medicine, Inc., Boston, MA, USA., Pattani V; Foundation Medicine, Inc., Boston, MA, USA., Huang RSP; Foundation Medicine, Inc., Boston, MA, USA., Wehn AK; Merck & Co., Inc., Rahway, NJ, USA.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2024 Sep 14; Vol. 8 (1), pp. 204. Date of Electronic Publication: 2024 Sep 14.
Autor:
Telli ML; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. mtelli@stanford.edu., Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beck JT; Department of Medical Oncology and Hematology, Highlands Oncology, Springdale, AR, USA., Jones JM; Avera Medical Group Oncology & Hematology, Avera Cancer Institute, Sioux Falls, SD, USA., Andersen J; Medical Oncology, Compass Oncology, West Cancer Center, US Oncology Network, Tigard, OR, USA., Mina LA; Hematology Oncology Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA., Brig R; Medical Oncology, Brig Center for Cancer Care and Survivorship, Knoxville, TN, USA., Danso M; Medical Oncology, Virginia Oncology Associates, Norfolk, VA, USA., Yuan Y; Department of Medical Oncology & Therapeutics Research, Cedars-Sinai Cancer Center, West Hollywood, CA, USA., Symmans WF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hopkins JF; Foundation Medicine, Inc., Cambridge, MA, USA., Albacker LA; Foundation Medicine, Inc., Cambridge, MA, USA., Abbattista A; Clinical Statistics, Pfizer Oncology, Milan, Italy., Noonan K; Clinical Oncology, Pfizer Inc., Groton, CT, USA., Mata M; Pfizer Inc., La Jolla, CA, USA., Laird AD; Pfizer Inc., South San Franciso, CA, USA., Blum JL; Department of Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas, TX, USA.
Publikováno v:
Breast cancer (Tokyo, Japan) [Breast Cancer] 2024 Sep; Vol. 31 (5), pp. 886-897. Date of Electronic Publication: 2024 Jun 13.
Autor:
Haberberger JF; Pathology Department, Foundation Medicine, Morrisville, NC, USA., Pegram W; Pathology Department, Foundation Medicine, Morrisville, NC, USA., Britt N; Pathology Department, Foundation Medicine, Morrisville, NC, USA., Schiavone K; Pathology Department, Foundation Medicine, Morrisville, NC, USA., Severson E; Pathology Department, Foundation Medicine, Morrisville, NC, USA., Sharaf R; Pathology Department, Foundation Medicine, Cambridge, MA, USA., Albacker LA; Pathology Department, Foundation Medicine, Cambridge, MA, USA., Williams E; Pathology Department, Foundation Medicine, Cambridge, MA, USA., Lechpammer M; Pathology Department, Foundation Medicine, Morrisville, NC, USA., Hemmerich A; Pathology Department, Foundation Medicine, Morrisville, NC, USA., Lin D; Pathology Department, Foundation Medicine, Morrisville, NC, USA., Huang RSP; Pathology Department, Foundation Medicine, Morrisville, NC, USA., Hiemenz M; Pathology Department, Foundation Medicine, Cambridge, MA, USA., Elvin J; Pathology Department, Foundation Medicine, Cambridge, MA, USA., Graf R; Pathology Department, Foundation Medicine, Cambridge, MA, USA., Lesser G; Pathology Department, Section on Hematology-Oncology, Wake Forest School of Medicine, Winston Salem, NC, USA., Kram D; Pathology Department, Section on Hematology-Oncology, Wake Forest School of Medicine, Winston Salem, NC, USA., Strowd R; Pathology Department, Section on Hematology-Oncology, Wake Forest School of Medicine, Winston Salem, NC, USA., Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Ramkissoon LA; Pathology Department, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Cohen MB; Wake Forest Comprehensive Cancer Center and Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA., Reddy P; Pathology Department, Foundation Medicine, Cambridge, MA, USA., Creeden J; Pathology Department, Foundation Medicine, Cambridge, MA, USA., Ross JS; Pathology Department, Foundation Medicine, Cambridge, MA, USA.; Pathology Department, SUNY Upstate Medical University, Syracuse, NY, USA., Alexander BM; Pathology Department, Foundation Medicine, Cambridge, MA, USA., Ramkissoon SH; Pathology Department, Foundation Medicine, Morrisville, NC, USA.; Wake Forest Comprehensive Cancer Center and Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Publikováno v:
The oncologist [Oncologist] 2024 Jan 05; Vol. 29 (1), pp. e47-e58.
Autor:
He J; Foundation Medicine, Inc, Cambridge, Massachusetts, USA., Kalinava N; CHDI Foundation, Princeton, New Jersey, USA., Doshi P; Gilead Sciences, Foster City, California, USA., Pavlick DC; Foundation Medicine, Inc, Cambridge, Massachusetts, USA., Albacker LA; Foundation Medicine, Inc, Cambridge, Massachusetts, USA., Ebot EM; Foundation Medicine, Inc, Cambridge, Massachusetts, USA., Tukachinsky H; Foundation Medicine, Inc, Cambridge, Massachusetts, USA., Pratt J; Bristol Myers Squibb, Princeton, New Jersey, USA., Fusaro G; Bristol Myers Squibb, Princeton, New Jersey, USA., Oxnard GR; Foundation Medicine, Inc, Cambridge, Massachusetts, USA., Green G; Bristol Myers Squibb, Princeton, New Jersey, USA., Fabrizio D; Foundation Medicine, Inc, Cambridge, Massachusetts, USA., Baden J; Solid Tumor Oncology Diagnostic Sciences, Bristol Myers Squibb, Princeton, New Jersey, USA jonathan.baden@bms.com.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Nov 30; Vol. 11 (11). Date of Electronic Publication: 2023 Nov 30.
Autor:
Turner NC; The Royal Marsden Hospital, The Institute of Cancer Research, London, UK. Nicholas.Turner@icr.ac.uk., Laird AD; Pfizer Inc., La Jolla, CA, USA., Telli ML; Stanford University School of Medicine, Stanford, CA, USA., Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Mailliez A; Department of Medical Oncology, Breast Cancer Unit, Centre Oscar Lambret, Lille, France., Ettl J; Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Grischke EM; Universitӓts Frauenklinik Tübingen, Eberhard Karls University, Tübingen, Germany., Mina LA; Banner MD Anderson Cancer Center, Gilbert, AZ, USA., Balmaña J; Hospital Vall d'Hebron, and Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Fasching PA; University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Hurvitz SA; University of California, Los Angeles/Jonsson Comprehensive Cancer Center (UCLA/JCCC), Los Angeles, CA, USA., Hopkins JF; Foundation Medicine Inc., Cambridge, MA, USA., Albacker LA; Foundation Medicine Inc., Cambridge, MA, USA., Chelliserry J; Pfizer Inc., La Jolla, CA, USA., Chen Y; Pfizer Inc., La Jolla, CA, USA., Conte U; Pfizer Inc., New York, NY, USA., Wardley AM; Manchester Breast Centre, Division of Cancer Sciences, University of Manchester, Manchester, UK., Robson ME; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2023 Oct 06; Vol. 9 (1), pp. 81. Date of Electronic Publication: 2023 Oct 06.
Autor:
Sharaf R; Foundation Medicine Inc., Cambridge, MA, USA., Jin DX; Foundation Medicine Inc., Cambridge, MA, USA., Grady J; Omico Australian Genomic Cancer Medicine, Sydney, Australia.; Garvan Institute of Medical Research, Sydney, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, Australia., Napier C; Omico Australian Genomic Cancer Medicine, Sydney, Australia.; Garvan Institute of Medical Research, Sydney, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, Australia., Ebot E; Foundation Medicine Inc., Cambridge, MA, USA., Frampton GM; Foundation Medicine Inc., Cambridge, MA, USA., Albacker LA; Foundation Medicine Inc., Cambridge, MA, USA., Thomas DM; Omico Australian Genomic Cancer Medicine, Sydney, Australia.; Garvan Institute of Medical Research, Sydney, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, Australia., Montesion M; Foundation Medicine Inc., Cambridge, MA, USA. mmontesion@foundationmedicine.com.
Publikováno v:
NPJ genomic medicine [NPJ Genom Med] 2023 Sep 14; Vol. 8 (1), pp. 26. Date of Electronic Publication: 2023 Sep 14.
Autor:
Ishiyama N; Black Diamond Therapeutics, Inc., New York, New York., O'Connor M; Black Diamond Therapeutics, Inc., New York, New York., Salomatov A; Black Diamond Therapeutics, Inc., New York, New York., Romashko D; Black Diamond Therapeutics, Inc., New York, New York., Thakur S; Black Diamond Therapeutics, Inc., New York, New York., Mentes A; Black Diamond Therapeutics, Inc., New York, New York., Hopkins JF; Foundation Medicine, Inc., Cambridge, Massachusetts., Frampton GM; Foundation Medicine, Inc., Cambridge, Massachusetts., Albacker LA; Foundation Medicine, Inc., Cambridge, Massachusetts., Kohlmann A; Black Diamond Therapeutics, Inc., New York, New York., Roberts C; Black Diamond Therapeutics, Inc., New York, New York., Buck E; Black Diamond Therapeutics, Inc., New York, New York.
Publikováno v:
Cancer research [Cancer Res] 2023 May 02; Vol. 83 (9), pp. 1531-1542.